Bay Area Biotech Investor

Why Endocyte's Small Molecule Drug Conjugates + Imaging Platform Is Undervalued

Endocyte (NASDAQ:ECYT) is a small-cap biopharmaceutical company valued at $457 million with 71 employees located in West Lafayette, Indiana. The company specializes in small molecule drug conjugates (SMDC) with companion imaging diagnostics to target cancer cells ONLY in patients likely to benefit. You can ...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
WITH SEEKING ALPHA PRO, INVESTORS CAN ALSO:
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
You are protected by the Seeking Alpha Money Back Guarantee and will get a prompt refund on the unused portion of your subscription at any time, for any reason.